ⅢB-Ⅳ期非小细胞肺癌多中心回顾性队列研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家重点研发计划项目(2018YFC1705102);首都卫生发展科研专项项目(2018-1-4201)


ⅢB-Ⅳ Stage Non-small Cell Lung Cancer:A Multicenter Retrospective Cohort Study
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨冷消融联合中药及化疗对ⅢB-Ⅳ期非小细胞肺癌患者生存期及生命质量的影响。方法:采用多中心回顾性队列研究的方法,纳入ⅢB-Ⅳ期非小细胞肺癌患者,经中药联合冷消融治疗患者133例,经化疗患者40例。比较2组患者生存期,绘制Kaplan-Meier生存曲线,分析实验室检查及生命质量评分差异,比较2种治疗模式对患者的影响。结果:冷消融联合中药与化疗治疗ⅢB-Ⅳ期非小细胞肺癌2组患者生存期比较差异无统计学意义。结论:冷消融联合中药与化疗比较可以显著提高患者治疗后生命质量,改善不良反应,在一定意义上冷消融联合中药治疗模式可以替代化疗。

    Abstract:

    To explore the effect of cryoablation combined with Chinese medicine and chemotherapy on the survival and quality of life of patients with stage ⅢB-Ⅳ non-small cell lung cancer.Methods:A multicenter retrospective cohort study was carried out.Patients with stage ⅢB-Ⅳ non-small cell lung cancer treated with cryoablation combined with Chinese medicine(n=133) or chemotherapy(n=40) were enrolled.The survival period of the patients in the two groups was compared and Kaplan-Meier survival curves were plotted.Differences in laboratory tests and quality of life scores were analyzed to compare the effect of the two treatment modes on patients.Results:There was no statistically significant difference in the survival period between the cryoablation combined with the Chinese medicine group and the chemotherapy group.Conclusion:Cryoablation combined with Chinese medicine significantly improved the quality of life of patients and reduced adverse reactions as compared with chemotherapy.In this sense,cryoablation combined with Chinese medicine treatment may be a replacement for chemotherapy.

    参考文献
    相似文献
    引证文献
引用本文

李媛,刘殿娜,代岳雯,孙静宜,胡凯文.ⅢB-Ⅳ期非小细胞肺癌多中心回顾性队列研究[J].世界中医药,2023,(10).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-10-13
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-06-06
  • 出版日期:
文章二维码